President Donald Trump’s declaration that he was taking an antimalarial drug of dubious effectiveness to help fend off the coronavirus will be welcomed in India.

Trump’s previous endorsement of hydroxychloroquine catalysed a tremendous shift in the South Asian country, spurring the world’s largest producer of the drug to make much more of it, prescribe it for front-line health workers treating the virus and deploy it as a diplomatic tool, despite mounting evidence against using the drug for Covid-19.

Trump recently said that he was taking hydroxychloroquine as a measure of protection against the virus. The US Food and Drug Administration, however, has cautioned against using it outside of hospitals because of the risk of serious heart problems.

Read full AP story here.

Opinion

Editorial

A new deal
Updated 16 Jun, 2026

A new deal

AFTER three and a half months of war between US-Israel and Iran and an acrimonious temporary ceasefire, a genuine...
Charter of economy
16 Jun, 2026

Charter of economy

NO one expected the PTI to accept the government’s invitation to sign a charter of economy; just as few expected...
Hostage seamen
16 Jun, 2026

Hostage seamen

SOME 50 days on, 11 Pakistani nationals are still in Somali pirates’ captivity. Their appeals to the Pakistani and...
Climate choices
Updated 15 Jun, 2026

Climate choices

The country is confronting increasingly volatile weather patterns with consequences for agriculture, infrastructure, public health and economic planning.
Brief opening
15 Jun, 2026

Brief opening

WE have been here before. Throughout the weekend, there was great anticipation that a tentative framework for peace...
Environmental disaster
15 Jun, 2026

Environmental disaster

IT was a heartbreaking sight. A recent news report in these pages carried a picture of a sea turtle lying half ...